VCI Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.7M Sell
8,662
-761
-8% -$148K 0.47% 44
2025
Q4
$1.64M Buy
+9,423
New +$1.72M 0.45% 55

Other funds holding DGX

VCI Wealth Management's DGX Position: Q1 2026 in Review

VCI Wealth Management reduced its Quest Diagnostics (DGX) stake by 8.1% in Q1 2026, selling an estimated $148K and leaving 8,662 shares worth $1.7M. The position accounts for 0.47% of the portfolio, ranked #44.

VCI Wealth Management first reported a position in DGX in Q4 2025 and has held it in 2 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • VCI Wealth Management held 8,662 shares of Quest Diagnostics worth $1.7M as of Q1 2026.
  • VCI Wealth Management sold 761 Quest Diagnostics shares in Q1 2026, an estimated $148K.
  • Quest Diagnostics made up 0.47% of VCI Wealth Management's portfolio in Q1 2026, its #44 holding.
  • VCI Wealth Management first reported a position in Quest Diagnostics in Q4 2025 and has held it in 2 quarters since.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on VCI Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.